Patient group input submissions: Ocrelizumab (Ocrevus) (Hoffmann-La Roche Limited)

Bibliographic Details
Corporate Authors: Multiple Sclerosis Society of Canada, Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2017, 2017
Series:CADTH common drug review
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Item Description:"Indication: Treatment of adult patients with relapsing-remitting multiple sclerosis (RRMS) with active disease defined by clinical and imaging features."
Physical Description:1 PDF file (5 pages)